Proteomics

Dataset Information

0

Trans-splicing of class I HLA bound peptides diversifies the immunopeptidome

ABSTRACT: The diversity of peptides displayed by class I HLA plays an essential role in T cell immunity. The peptide repertoire is extended by various post-translational modifications, including cis-splicing of peptides from the same protein. Here, we have applied a novel bioinformatic workflow and demonstrate that spliced-peptides are also generated through trans-splicing (fusion of peptide segments from distinct antigens) and their abundance challenges current models of proteasomal-splicing that predict cis-splicing as the most probable outcome. These trans-spliced peptides display canonical HLA binding motif sequence features. These results highlight the unanticipated diversity of the immunopeptidome and have important implications for autoimmunity, vaccine design and immunotherapy.

INSTRUMENT(S): TripleTOF 5600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, Cell Suspension Culture, Cell Culture

SUBMITTER: Nathan Croft  

LAB HEAD: Anthony W Purcell

PROVIDER: PXD009660 | Pride | 2018-10-16

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
20140205_SR_B0702_gp160_A1.mzxml Mzxml
20140205_SR_B0702_gp160_A10.mzxml Mzxml
20140205_SR_B0702_gp160_A11.mzxml Mzxml
20140205_SR_B0702_gp160_A12.mzxml Mzxml
20140205_SR_B0702_gp160_A13.mzxml Mzxml
Items per page:
1 - 5 of 96
altmetric image

Publications

The diversity of peptides displayed by class I human leukocyte antigen (HLA) plays an essential role in T cell immunity. The peptide repertoire is extended by various posttranslational modifications, including proteasomal splicing of peptide fragments from distinct regions of an antigen to form nongenomically templated cis-spliced sequences. Previously, it has been suggested that a fraction of the immunopeptidome constitutes such cis-spliced peptides; however, because of computational limitation  ...[more]

Similar Datasets

Proteomics Trans-splicing of class I HLA bound peptides diversifies the immunopeptidome
2021-12-06 | PXD017922 | Pride
Proteomics SPI-ART and the features of cis-spliced peptides in HLA class I immunopeptidomes
2022-08-12 | PXD025346 | Pride
Proteomics HLA-DR ligands from BLCLs 9022 and 9087
2020-03-11 | PXD017682 | Pride
Proteomics Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection
2019-11-25 | PXD015489 | Pride
Proteomics Influenza-derived peptide presentation by HLA-A*24:02
2021-04-08 | PXD020292 | Pride
Proteomics Identification of HLA-B*57:01-restricted endogenous and HIV epitopes
2018-02-19 | PXD004471 | Pride
Proteomics Large-Scale Immuno-Peptidome Analysis Reveals Recurrent Post-Translational Splicing of Cancer and Immune-Associated Genes
2023-05-10 | PXD034788 | Pride
Proteomics Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome
2023-05-10 | PXD040860 | Pride
Proteomics Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome
2018-09-03 | PXD010793 | Pride
Proteomics HLA-DQ8 Immunopeptidomics, Type 1 Diabetes
2021-07-07 | PXD019466 | Pride